[Federal Register: December 8, 2006 (Volume 71, Number 236)]
[Rules and Regulations]               
[Page 71243-71337]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08de06-16]                         


[[Page 71243]]

-----------------------------------------------------------------------

Part II





Department of Health and Human Services





-----------------------------------------------------------------------



Centers for Medicare & Medicaid Services



-----------------------------------------------------------------------



42 CFR Parts 460, 462, 466, 473, and 476



Medicare and Medicaid Programs; Programs of All-Inclusive Care for the 
Elderly (PACE); Program Revisions; Final Rule


[[Page 71244]]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Parts 460, 462, 466, 473, and 476

[CMS-1201-F]
RIN 0938-AN83

 
Medicare and Medicaid Programs; Programs of All-Inclusive Care 
for the Elderly (PACE); Program Revisions

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This rule finalizes the interim final rule with comment period 
published in the Federal Register November 24, 1999 (64 FR 66234) and 
the interim final rule with comment period published in the Federal 
Register on October 1, 2002 (67 FR 61496). The November 1999 interim 
final rule implemented sections 4801 through 4803 of the Balanced 
Budget Act of 1997 (Pub. L. 105-33) and established requirements for 
Programs of All-inclusive Care for the Elderly (PACE) under the 
Medicare and Medicaid programs. The interim final rule with comment 
period published on October 1, 2002 (67 FR 61496) implemented section 
903 of the Medicare, Medicaid, and SCHIP Benefits Improvement and 
Protection Act of 2000 (BIPA) (Pub. L. 106-554).

DATES: Effective Date: These regulations are effective on January 8, 
2007.

FOR FURTHER INFORMATION CONTACT: Jana Petze, (410) 786-4533, or Carrie 
Smith, for State technical assistance, (410) 786-4485.

SUPPLEMENTARY INFORMATION:

Table of Contents

I. Background
    A. Program Description
    B. Legislative History
    1. Demonstration Project
    2. Balanced Budget Act (BBA) of 1997 (Pub. L. 105-33)
    a. Use of the PACE Protocol
    b. Consultation With States
    c. Consultation With State Agency on Aging
    d. State Medicaid Plan Requirement
    e. Interaction with Medicare + Choice (Now Medicare Advantage)
    f. Flexibility Under the BBA
    3. The Medicare, Medicaid, and SCHIP Benefits Improvement and 
Protection Act of 2000 (BIPA)
    a. Background
    b. Contracting for IDT Members and Administrative Staff
    c. Contracting With Another Entity to Furnish PACE Center 
Services
    d. Oversight of Direct Patient Care Services
    e. Waiver Process
    4. Medicare Prescription Drug Improvement and Modernization Act 
of 2003, (MMA)
II. Analysis of Public Comments
    A. Summary of Comments on the 1999 Interim Final Rule
    B. Summary of Comments on the 2002 Interim Final Rule
III. Provisions of the 1999 Interim Final Rule With Comment and the 
2002 Interim Final Rule With Comment, Analysis of and Response to 
Public Comments and Final Rule Actions
IV. Provisions of the Final Rule
V. Collection of Information Requirements
VI. Regulatory Impact Statement
Regulation Text
Addendum--PACE Protocol (1999)

ACRONYMS for the PACE Final Rule

ADLs Activities of Daily Living
BBA Balanced Budget Act of 1997
BIPA Medicare, Medicaid and SCHIP Benefits Improvement and Protection 
Act of 2000
CAP Corrective Action Plan
CBRR Consumer Bill of Rights and Responsibilities
CMS Centers for Medicare & Medicaid Services
COBRA Consolidated Omnibus Budget Reconciliation Act of 1985
COP Condition of Participation
CHSPR Center for Health Services and Policy Research
CMS-HCC CMS Hierarchical Conditions Category
ESRD End-Stage Renal Disease
FFP Federal Financial Participation
HOS Health Outcomes Survey
HPMS Health Plan Management System
IDT Interdisciplinary Team
IRE Independent Review Entity
LCS Life Safety Code
MA Medicare Advantage (formerly Medicare + Choice(M + C))
MA-PDP Medicare Advantage--Prescription Drug Plan
M + C Medicare + Choice (now Medicare Advantage (MA))
MMA Medicare Prescription Drug[fxsp0]Improvement 
and[fxsp0]Modernization Act of 2003
NF Nursing Facility
NPA National PACE Association
OBCQI Outcome-Based Continuous Quality Improvement
PACE Programs of All-inclusive Care for the Elderly
PCA Personal Care Attendant
PCP Primary Care Physician
PHS PACE Health Survey
PO PACE Organization
QAPI Quality Assessment and Performance Improvement
RAI Request for Additional Information
SAA State Administering Agency
SFH State Fair Hearing
SPA State Plan Amendment
SSA Social Security Administration

Requirements for Issuance of Regulations

    Section 902 of the Medicare Prescription Drug, Improvement, and 
Modernization Act of 2003 (MMA) (Pub. L. 108-173 enacted on December 8, 
2003, amended section 1871(a) of the Social Security Act (the Act)) 
requires the Secretary, in consultation with the Director of the Office 
of Management and Budget, to establish and publish timelines for the 
publication of Medicare final regulations based on the previous 
publication of a Medicare proposed or interim final regulation. Section 
902 of the MMA states that the timelines for these regulations may vary 
among different regulations but shall not exceed 3 years after 
publication of the preceding proposed or interim final regulation 
except under exceptional circumstances. Section 902 also directs the 
Secretary to establish an appropriate period for finalizing those 
interim final regulations that were published before the enactment of 
MMA on December 8, 2003. Pursuant to this requirement, we published a 
notice in the Federal Register (69 FR 78442) establishing a publication 
deadline of 3 years from MMA enactment, that is December 8, 2006, for 
finalizing interim final rules published prior to MMA enactment.
    This final rule finalizes provisions set forth in the November 24, 
1999 and October 1, 2002 interim final rules with comment. These 
interim final regulations will be finalized within the 3-year period 
after MMA enactment that was established under section of the MMA 902. 
Therefore, we believe that this final rule is in accordance with the 
Congress' intent to ensure timely publication of final regulations.

I. Background

A. Program Description

    The Program of All-inclusive Care for the Elderly (PACE) program is 
a unique model of managed care service delivery for the frail 
community-dwelling elderly, most of whom are dually eligible for 
Medicare and Medicaid benefits, and all of whom are assessed as being 
eligible for nursing home placement according to the standards 
established by their respective States.

B. Legislative History

1. Demonstration Project
    Section 603(c) of the Social Security Amendments of 1983 (Pub. L. 
98-21), as extended by section 9220 of the Consolidated Omnibus Budget

[[Page 71245]]

Reconciliation Act of 1985 (COBRA) (Pub. L. 99-272) authorized the 
original demonstration PACE program for On Lok Senior Health Services 
(On Lok) in San Francisco. Section 9412(b) of Pub. L. 99-509, the 
Omnibus Budget Reconciliation Act of 1986 (OBRA, 1986), authorized us 
to conduct a PACE demonstration program to determine whether the model 
of care developed by On Lok could be replicated across the country. The 
number of sites was originally limited to 10, but the Omnibus Budget 
Reconciliation Act of l990 (Pub. L. 101-508) authorized an increase to 
15 PACE demonstration programs.
    The PACE model of care includes as core services the provision of 
adult day health care and interdisciplinary team (IDT) care management, 
through which access to and allocation of all health services is 
managed. Physician, therapeutic, ancillary, and social support services 
are furnished in the participant's residence or on-site at a PACE 
center. Hospital, nursing home, home health, and other specialized 
services are generally furnished under contract. Financing of the PACE 
demonstration model was accomplished through prospective capitation of 
both Medicare and Medicaid. PACE demonstration programs had been 
permitted by section 4118(g) of Pub. L. 100-203 (OBRA 1987) to assume 
full financial risk progressively over the initial three years. As such 
authority was removed by section 4803(b)(1)(B) of the Balanced Budget 
Act of 1997 (BBA) (Pub. L. 105-33), PACE demonstration programs 
approved after August 5, 1997 had to assume full financial risk at 
start-up.
    The PACE demonstration program was operated under a Protocol 
established and published by On Lok, Inc. on April 4, 1995.
2. Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33)
    The BBA built on the success of the PACE demonstration program. 
Section 4801 of the BBA, authorized coverage of PACE under the Medicare 
program. It amended title XVIII of the Act by adding section 1894, 
which addresses Medicare payments and coverage of benefits under PACE. 
Section 4802 of the BBA authorized the establishment of PACE as a State 
option under Medicaid. It amended title XIX of the Act by adding 
section 1934, which directly parallels the provisions of section 1894. 
Section 4803 of the BBA addresses implementation of PACE under both 
Medicare and Medicaid, the effective date, timely issuance of 
regulations, priority and special consideration in processing 
applications, and transition from PACE demonstration program status.
    As directed by section 4803 of BBA, we published an interim final 
rule on November 24, 1999, permitting entities to establish and operate 
PACE programs under section 1894 and 1934 of the Act (64 FR 66234).
    The 1999 interim final rule was a comprehensive rule that addressed 
eligibility, administrative requirements, application procedures, 
services, payment, participant rights, and quality assurance.
a. Use of the PACE Protocol
    Throughout the 1999 interim final rule, when we referred to ``the 
Protocol'' we meant the PACE Protocol, as published by On Lok, Inc., 
the parent company of On Lok Senior Health Services. A copy of the 
Protocol was included as an attachment to the 1999 interim final rule 
with comment period.
    We were directed by sections 1894(f)(2) and 1934(f)(2) of the Act 
to incorporate into regulation the requirements applied to PACE 
demonstration programs under the Protocol, to the extent consistent 
with the provisions of sections 1894 and 1934 of the Act. We also were 
authorized to modify or waive certain provisions of the Protocol in the 
development of the regulation, if the modification or waiver were not 
inconsistent with and would not impair the essential elements, 
objectives, and requirements of sections 1894 and 1934 of the Act.
b. Consultation With States
    Sections 4801 and 4802 of Pub. L. 105-33 clearly dictate a 
cooperative relationship between the Secretary and the States in the 
development, implementation and administration of the PACE program. In 
order to fulfill these requirements, we utilized the American Public 
Human Services (formerly, the American Public Welfare Association) as 
the conduit to solicit States for volunteers to consult with CMS staff. 
The participating State staff members represented States with a range 
of PACE experience. Each State staff volunteer selected a specific 
target area to provide information.
    In order to efficiently and effectively obtain a large amount of 
feedback in a short period of time, CMS staff arranged a series of 
conference calls to discuss a wide range of issues pertaining to PACE 
including requirements on the application process, enrollment, and 
payment and related financial data collection. Each subject area 
discussion included CMS staff and two to three State representatives. 
The feedback obtained during these meetings was an invaluable source of 
information in understanding State operational concerns and in 
constructing the regulation. We believed that this approach would 
minimize operational barriers that are frequently inherent when new 
programs are initiated. For this reason, CMS continues to regularly 
consult and receive feedback from States regarding PACE policy by means 
of teleconferences and forums.
c. Consultation With State Agency on Aging
    Under the Older Americans Act, State Agencies on Aging were charged 
with the responsibility of promoting comprehensive and coordinated 
service systems for older persons in their States. Consistent with this 
responsibility, State Agencies on Aging oversee important programs for 
home and community-based services which are funded through title III of 
the Older Americans Act, State revenues, and the Medicaid home and 
community-based waiver program.
    The State agencies also implement and oversee important planning, 
referral, case management, and quality assurance functions. In 
addition, State agencies are responsible for administering the State 
Long Term Care Ombudsman Program through which service quality in 
nursing homes and board and care homes are monitored in every State.
    Each State agency that administers the PACE program should 
regularly consult with their respective State Agency on Aging in order 
to avoid service duplication in the PACE service areas and to assure 
the delivery and quality of services to PACE participants. In our 1999 
interim final rule, we indicated we were considering the extent to 
which the State Long Term Care Ombudsman Program would be useful in 
promoting the rights of PACE participants and in monitoring the quality 
of care provided by PACE organizations (POs). We received a number of 
comments on this issue that we discuss in Subpart G ``Participant 
Rights'' of this final rule.
d. State Medicaid Plan Requirement
    The State Medicaid plan is a comprehensive written statement 
submitted by the State and approved by CMS describing the nature and 
scope of the Medicaid program and giving assurance that the Medicaid 
program will be administered according to Federal law and policy. The 
State plan preprint sets forth the scope of the Medicaid program, 
including groups covered, services furnished, and

[[Page 71246]]

payment policy. When a State completes a new State plan preprint page 
because of changes in its Medicaid program (called a ``State plan 
amendment (SPA)''), the preprint page must be approved by CMS in order 
for the State to receive Federal matching funds.
    Section 1905(a)(26) of the Act, as added by section 4802(a)(1) of 
the BBA, provided authority for States to elect PACE as an optional 
Medicaid benefit. The State plan electing the optional PACE program 
must be approved before CMS and the State enter into a program 
agreement with a PO. To aid States in modifying their State plans, the 
CMS Center for Medicaid and State Operations developed an interim State 
plan preprint for PACE. A State Medicaid letter dated March 23, 1998, 
provided information and guidance to State Medicaid agencies on how to 
satisfy the State plan amendment requirement. Additional directions for 
completing the State plan amendment were provided in a State Medicaid 
Director letter that was issued November 9, 2000. The most current 
version of the State Plan preprint is available on the CMS PACE 
homepage, http://www.cms.hhs.gov/PACE/04_InformationforStateAgencies.asp
.

e. Interaction With Medicare+Choice (Now Medicare Advantage)
    The BBA also established the Medicare+Choice (M+C) program, which 
expanded the health care options available to Medicare beneficiaries. 
Under the M+C program, beneficiaries could elect to receive Medicare 
benefits through enrollment in one of several private health plan 
choices beyond the original (fee-for-service) Medicare program or 
choose a plan previously available through managed care organizations 
under section 1876 of the Act.
    The BBA set forth the requirements for M+C organizations in a new 
Part C of title XVIII of the Act. The interim final rule that 
implemented the M+C program was published June 26, 1998 (63 FR 34968). 
The final regulation addressing comments was published on February 17, 
1999 (64 FR 7968).
    Significant changes were made to the M+C program by the Medicare 
Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) 
(Pub. L. 108-173, enacted on December 8, 2003). The two final 
regulations that implemented the MMA were published January 28, 2005 
(70 FR 4194 and 4588). The first regulation established the Medicare 
Prescription Drug Benefit or Medicare Part D and the second regulation 
established the Medicare Advantage (MA) program which replaced the M+C 
program.
    In this final rule, we are finalizing our regulations that 
implement the PACE provisions of the BBA and BIPA statutes. We are 
limiting our discussion of the effects of MMA provisions to those 
issues that have been addressed in other MMA rulemaking. We think our 
regulations on Part D and MA provide sufficient and appropriate 
guidance to all affected entities, including POs. However, we believe 
it is essential to highlight the impact of MMA, particularly with 
respect to how Medicare Part D relates to a PO. Specifically, the MMA 
provides that POs electing to provide Part D coverage to their 
enrollees shall be treated in a manner similar to Medicare Advantage 
Prescription Drug Plans (MA-PDPs). A more detailed discussion of the 
relevant MMA provisions is provided later in this section.
    Although the PACE program has certain fundamental similarities to 
M+C (now MA), PACE is not a M+C plan. The BBA established separate and 
distinct requirements for the PACE program. PACE is similar to some M+C 
options in these ways: it is capitated; it is risk-based; it provides 
managed care; and it is an elective option. However, PACE differs 
significantly from M+C plans in other ways such as: it is not available 
nationwide (only in a limited number of sites); statutory waivers 
expand the scope of Medicare covered services; it is not available to 
all beneficiaries (only to a defined subset of frail elderly); and it 
is a joint Medicare/Medicaid program. However, the BBA directed us to 
consider some of the requirements established for the M+C program as we 
developed regulations for POs in certain areas common to both programs, 
for example, beneficiary protections, payment rates, and sanctions.
f. Flexibility Under the BBA
    As noted above, the PACE demonstration program was operated 
pursuant to a Protocol developed by On Lok, Inc. The Protocol provided 
authority for CMS and the State Administering Agency (SAA) (that is, 
the State Agency designated to administer the PACE program) to waive 
specific requirements of the Protocol, if, in their judgment, the 
following criteria were met:
     The intent of the requirements was met by the proposed 
alternative and
     Safe and quality care would be provided.

In addition, written requests for waivers were required to be approved 
by CMS and the SAA before implementation of the proposed alternative.
    Flexibility was limited to the requirements in the section on 
service coverage and arrangement. That section includes the following 
requirements:
     POs must provide all Medicare and Medicaid services and 
provide care 7 days per week, 365 days per year;
     A listing of required and excluded services and minimum 
services;
     Each participant be assigned to an IDT;
     The composition and duties of the IDT;
     The assessment and reassessment requirements.
    Flexibility was not authorized for other sections of the Protocol, 
such as participant rights, enrollment and disenrollment, and 
administration.
    Sections 1894(f)(2)(B) and 1934(f)(2)(B) of the Act give the 
Secretary the authority to waive regulatory provisions as follows:

    In order to provide for reasonable flexibility in adapting the 
PACE service delivery model to the needs of particular organizations 
(such as those in rural areas or those that may determine it 
appropriate to use non-staff physicians according to State licensing 
law requirements) * * * the Secretary (in close consultation with 
State administering agencies) may modify or waive provisions of the 
PACE protocol as long as the modification or waiver is consistent 
with and would not impair the essential elements, objectives, and 
requirements of this section * * *.

    The statute also specifies the following essential elements that 
may not be waived:
     The focus on frail elderly qualifying individuals who 
require the level of care provided in a nursing facility.
     The delivery of comprehensive, integrated acute and long-
term care services.
     The multidisciplinary team approach to care management and 
service delivery.
     Capitated, integrated financing that allows the provider 
to pool payments received from public and private programs and 
individuals.
     The assumption by the provider of full financial risk.
    To implement sections 1894(f)(2)(B) and 1934(f)(2)(B) of the Act, 
in the 1999 interim final rule, we identified specific waivers that 
were intended to encourage the development of PACE programs in rural 
and Tribal areas. The waivers included the following three 
requirements:
     A prohibition on members of the governing body and their 
family members from having a direct or indirect interest in contracts 
with the organization (see Sec.  460.68(c));

[[Page 71247]]

     A requirement that members of the IDT primarily serve PACE 
participants (see Sec.  460.102(g)); and
     A requirement that the primary care physician (PCP) must 
be employed by the PO (see Sec.  460.102(g)).
    The regulation included specific criteria for each waiver related 
to whether the PO's service area is rural or Tribal, the accessibility 
of individuals who meet the three regulatory requirements listed above, 
and a requirement that the proposed alternative does not adversely 
affect the availability or quality of care furnished to PACE 
participants.
    Our rationale for this initial, limited view of the flexibility 
provision was based on our belief that all PACE demonstration programs 
were in compliance with the Protocol, necessitating only minor changes 
in their operations to meet the PACE regulatory requirements. Our 
intention was to allow some flexibility to promote PACE in rural and 
Tribal areas while maintaining consistency of the requirements for 
other PACE programs. We intended to provide more flexibility to all POs 
once we had gained sufficient experience in administering the PACE 
program.
    However, after publication of the 1999 interim final rule, we 
learned that although the early PACE demonstration programs initially 
complied with the Protocol, most of them modified the Protocol 
requirements as they expanded, using the flexibility authorized in the 
Protocol. While many of these modifications were related to the 
allowable areas of service coverage and arrangement provisions, many 
others were not authorized by the flexibility clause in the Protocol. 
Furthermore, many of the later PACE demonstration programs also 
inappropriately exercised the flexibility clause in the Protocol, 
especially with regard to direct employment of staff. Finally, very few 
of the waivers were requested in writing or approved by CMS or the SAA 
before implementation.
    We subsequently revised our regulations on the waiver process in 
response to comments on the 1999 interim final rule and in accordance 
with the requirements of section 903 of the Medicare, Medicaid, and 
SCHIP Benefits Improvement and Protection Act of 2000 (BIPA) (Pub. L. 
106-554, enacted on December 21, 2000), as discussed below. A detailed 
discussion of waivers and the waiver process is located in section III, 
subpart B of this final rule.
3. The Medicare, Medicaid, and SCHIP Benefits Improvement and 
Protection Act of 2000 (BIPA)
a. Background
    BIPA modified the PACE program in the following three ways:
     Section 901 extended the transition period for the PACE 
demonstration programs to allow an additional year for these 
organizations to transition to the permanent PACE program.
     Section 902 gave the Secretary the authority to 
grandfather in the modifications these programs had implemented as of 
July 1, 2000. This provision allowed the PACE demonstration programs to 
continue program modifications they had implemented and avoid 
disruptions in participant care where these modifications were 
determined to be consistent with the PACE model. These sections were 
implemented administratively.
     Section 903 specifically addressed flexibility in 
exercising the waiver authority provided under sections 1894(f)(2)(B) 
and 1934(f)(2)(B) of the Act. It authorized CMS to modify or waive PACE 
regulatory provisions in a manner that responds promptly to the needs 
of POs relating to the areas of employment and the use of community-
based PCPs. Section 903 of BIPA also established a 90-day review period 
for waiver requests. As the flexibility language is part of the 
statutory section dealing with regulations (sections 1894(f) and 
1934(f) of the Act), we believed it was intended that waiver 
requirements be incorporated into the PACE regulations. In order to 
implement section 903 of BIPA, we published the 2002 PACE interim final 
rule.
b. Contracting for IDT Members and Administrative Staff
    In the 2002 interim final rule, we amended the PACE regulations to 
replace the term ``multidisciplinary'' with ``interdisciplinary'' to 
more accurately reflect the interactive and collaborative approach of 
the PACE care team.
    In the 2002 interim final rule, we responded to public comments 
regarding flexibility, including comments on Sec.  460.102(f) of the 
1999 interim final rule, which required that the PACE IDT members be 
employees of the PO or PACE center. In the 2002 interim final rule, we 
deleted Sec.  460.102(f) and revised Sec.  460.60 to allow the PO to 
employ or contract with the program director and the medical director. 
We also added requirements at Sec.  460.70 that must be met when the PO 
is contracting for services.
    A more detailed discussion of Sec.  460.60 and Sec.  460.70 is 
located in section III, subpart E of this final rule.
c. Contracting With Another Entity To Furnish PACE Center Services
    After publication of the 1999 interim final rule, we learned that 
in 1995, On Lok, Inc. had changed the Protocol to reflect a contractual 
arrangement they entered into with another organization to provide all 
PACE center services. Under this arrangement, the IDT was employed and 
managed by the contracting organization but On Lok retained 
responsibility for all care provided to and all risk entailed in 
meeting the healthcare needs of the participants attending the center. 
Through this contractual relationship, On Lok was able to expand PACE 
services within their service area. As this approach was reflected in 
the PACE Protocol, we amended the PACE regulations in the 2002 interim 
final rule to allow POs to provide PACE center services through 
contractual arrangements. We also revised Sec.  460.70 to identify the 
criteria that a PO must meet to contract out PACE center services. A 
more detailed discussion of Sec.  460.70 is located in section at IV.B. 
of this final rule.
d. Oversight of Direct Patient Care Services
    As discussed above, in the 2002 interim final rule, we revised the 
requirements of the 1999 interim final rule to allow for the 
contracting of IDT members, program director, medical director, and all 
PACE center services. For this reason, we believed it was essential to 
establish oversight criteria that POs must implement for all employees 
and contracted staff who furnish direct patient care. This was 
accomplished with the addition of Sec.  460.71. A more detailed 
description of Sec.  460.71 is located in section IV, subpart E of this 
final rule.
e. Waiver Process
    To implement section 903 of BIPA, we established a process for 
submission and approval of waiver requests. The 2002 interim final rule 
amended the 1999 interim final rule by adding Sec.  460.26, which 
specifies the requirements for submission and evaluation of waiver 
requests and Sec.  460.28, which addresses requirements related to CMS 
review of waiver requests. In the 2002 interim final rule, we also 
removed the restrictive waiver provisions for rural and Tribal

[[Page 71248]]

organizations that were included in the 1999 interim final rule.
    A more detailed description of Sec.  460.26 and Sec.  460.28 is 
located in section III, subpart B of this final rule.
4. Medicare Prescription Drug Improvement and Modernization Act of 2003 
(MMA)
    On December 8, 2003, the Congress enacted the MMA of 2003 (Pub. L. 
108-173). Several sections of the MMA impact POs. Most notably, section 
101 of the MMA affected the way in which POs are paid for providing 
certain outpatient prescription drugs to any Part D eligible 
participant. As specified in sections 1894 and 1934 of the Act, POs 
shall provide all medically necessary services including prescription 
drugs, without any limitation or condition as to amount, duration, or 
scope and without application of deductibles, co-payments, coinsurance, 
or other cost sharing that would otherwise apply under Medicare or 
Medicaid. Up until January 1, 2006, payment for drugs covered under 
Medicare parts A and B was included in the monthly Medicare capitation 
rate paid to POs for Medicare beneficiaries, while payment for 
outpatient prescription drugs was included in the monthly Medicaid 
capitation rate paid to POs for Medicaid recipients, or as a portion of 
the amount equal to the Medicaid premium paid by non-Medicaid 
recipients.
    Consequently, in order for POs to continue to meet the statutory 
requirement of providing prescription drug coverage to their enrollees, 
and to ensure that they receive adequate payment for the provision of 
Part D drugs, beginning January 1, 2006, POs could begin to offer 
qualified prescription drug coverage to their enrollees who are Part D 
eligible individuals. The MMA did not impact the manner in which POs 
are paid for the provision of outpatient prescription drugs to non-part 
D eligible PACE participants.
    Section 1860D-21(f) of the Act, added by section 101 of the MMA, 
provides that POs may elect to provide qualified prescription drug 
coverage to enrollees who are Part D eligible individuals.
    This section also provides that in the case of a PACE program that 
elects to provide qualified Part D prescription drug coverage, the 
requirements under Part D apply to the provision of such coverage in a 
manner that is similar to the manner in which those requirements apply 
to the provision of such coverage under an MA-PD local plan. However, 
because we did not believe that Congress intended for the MMA to alter 
the way in which PACE services, including outpatient prescription drugs 
are provided to PACE enrollees, we indicated in the final rule that 
implements Part D (70 FR 4194) that POs would not be deemed to be MA-PD 
local plans, but rather, would be treated in a manner similar to an MA-
PD local plan for purposes of payment under Part D. We stated that this 
approach is consistent with section 1894(d)(1) of the Act, which 
provides that payments will be made to POs ``in the same manner and 
from the same sources'' as payments are made to a MA organization.
    The MMA allows CMS the flexibility to deem POs as MA-PD plans or to 
treat POs that elect to provide qualified drug coverage in a manner 
similar to MA-PD plans. Due to inconsistencies in the PACE and MMA 
statutes, we chose to treat POs in a similar manner as MA-PD plans 
avoiding conflicting requirements. The requirements that apply to POs 
that elect to provide qualified prescription drug coverage to Part D 
eligible enrollees are set forth in subpart T of the preamble to the 
Part D final rule (70 FR 4194). To the extent that we need to address 
additional issues regarding Part D as it applies to POs, we will do so 
in a future rulemaking.
    In addition, section 236 of the MMA amended the Act to extend to 
POs the existing statutory Medicare and Medicaid balance billing 
protections that had previously applied to POs under PACE demonstration 
program authority. Specifically, provisions of the Act that limit 
balance billing against MA organizations by non-contract physicians, 
providers of service, and other entities with respect to services 
covered under title XVIII now include PACE providers. Similarly, 
Medicaid billing limitations specified in the Act now apply to 
providers participating under the State plan under title XIX that do 
not have a contract or other agreement with a PACE provider. Both MMA 
provisions apply to services furnished on or after January 1, 2004.
    Section 301 of the MMA amends the Medicare Secondary Payer (MSP) 
provisions in section 1862(b) of the Act. These amendments clarify the 
obligations of primary plans and primary payers, the nature of the 
insurance arrangements subject to the MSP rules, the circumstances 
under which Medicare may make conditional payments, and the obligations 
of primary payers to reimburse Medicare. To implement section 301 of 
the MMA, we issued an interim final rule with comment period (71 FR 
9466), published on February 24, 2006, revising our MSP regulations at 
part 411. Our PACE regulations at Sec.  460.180(d) specify that 
Medicare does not pay for PACE services to the extent that Medicare is 
not the primary payer under part 411. The MSP interim final rule 
establishes our current policies regarding the obligations of other 
payers. If there are any provisions specific to PACE organizations that 
result from issuance of the final MSP rule, we will address those 
provisions in a future PACE rulemaking.
    Finally, as discussed above, under the rulemaking requirements of 
section 902 of the MMA and our notice in the Federal Register on 
December 30, 2004 (69 FR 78442), interim final regulations issued 
before enactment of MMA on December 8, 2003 must be finalized within 3 
years of the date of enactment or the regulations shall not continue in 
effect. This rule finalizes both the PACE interim final rule with 
comment period published in the Federal Register November 24, 1999 (64 
FR 66234) and the PACE interim final rule with comment period published 
in the Federal Register on October 1, 2002 (67 FR 61496).

II. Analysis of and Response to Public Comments

    This final rule responds to public comments received on both the 
November 24, 1999 interim final rule with comment (64 FR 66234) and the 
October 1, 2002 interim final rule with comment (67 FR 61496).

A. Summary of Comments on the 1999 Interim Final Rule

    We received 34 items of correspondence containing more than 500 
specific comments on the 1999 interim final rule. In this document, we 
will refer to this regulation as the 1999 interim final rule. 
Commenters included representatives of professional associations, State 
and county governments, PACE demonstration programs, potential PACE 
programs, various health care providers, and advocacy organizations.
    Consistent with the scope of the 1999 interim final rule, most of 
the commenters addressed multiple issues, often in great detail. Some 
commenters expressed concerns about Medicare and Medicaid issues that 
do not pertain to the PACE program.
    Numerous commenters disapproved of the limited flexibility provided 
in the regulation, stating that the regulation restricts programs from 
developing innovatively and responsively to participant preferences, 
community needs, and the healthcare marketplace. They asked for 
operational and service delivery flexibility, while permitting

[[Page 71249]]

liberal exceptions for established programs that have proven success in 
furnishing the PACE benefit. Commenters also noted the regulatory 
language was too prescriptive in several key areas (personnel 
qualifications) and too vague in others (Medicare rate-setting), saying 
that prescriptive language also reduces flexibility in organizational 
design and limits innovative strategies for service delivery.
    Commenters indicated that the application of M+C requirements was 
often made without considering the differences between the PACE program 
and M+C plans and that the differences between PACE and nursing 
facilities should be recognized in the final requirements.
    In addition, commenters indicated that the numerous written notices 
required by the 1999 interim final rule were unduly burdensome.
    Comments also indicated that in some instances requirements from 
other programs (for example, the Outcome Assessment Information Set 
(OASIS) for home health agencies) have been applied to PACE, thereby 
disregarding the differences between the programs and adding the burden 
of information collection.
    Finally, commenters opposed the prescriptive language that they 
thought limited State discretion and usurped traditional State 
regulatory activities rather than optimizing the opportunity to 
encourage cooperation with the States. We respond to the particular 
comments as they relate to specific provisions discussed in section III 
of this final rule.
    Listed below are the six areas of the 1999 interim final rule that 
generated the most concern:
    Subpart D: Sanctions, Enforcement Actions and Termination including 
civil money penalties;
    Subpart E: PACE Administrative Requirements including 
organizational structure, personnel qualifications, contracted services 
and marketing;
    Subpart F: PACE Services including the interdisciplinary team and 
participant assessment;
    Subpart G: Participant Rights including the appeals process;
    Subpart I: Participant Enrollment and Disenrollment which includes 
eligibility to enroll, enrollment process, continuation of enrollment, 
and involuntary disenrollment;
    Subpart J: Payment including Medicare payment.

B. Summary of Comments on the 2002 Interim Final Rule

    We received 4 letters of public comment on the October 1, 2002 
interim final rule (67 FR 61496) containing more than 17 specific 
comments. Commenters included representatives of professional 
associations, a State government, and an advocacy organization. In this 
document, we will refer to this regulation as the 2002 interim final 
rule.
    Commenters expressed opposing opinions on the flexibility permitted 
in the 2002 interim final rule. In general, commenters expressed 
concerns about flexibility related to all aspects of the program, 
including waivers and the waiver process, contracted services including 
staff and contractors, and oversight of direct participant care. Listed 
below are the three areas that generated the most concern:
    Subpart B: PO Application and Waiver Process;
    Subpart D: Sanctions, Enforcement Actions and Termination;
    Subpart E: Administrative Requirements.

III. Provisions of the 1999 Interim Final Rule With Comment and the 
2002 Interim Final Rule With Comment, Analysis of and Responses to 
Comments and Final Rule Actions

    The purpose of this final rule is to respond to public comments and 
finalize the regulations established in the 1999 and 2002 interim final 
rules. Below we will list each PACE regulation, note any comments and 
responses, and then note our final action.

Subpart A--Basis, Scope, and Purpose

    This subpart provides the basis for this regulation, the scope and 
purpose, and defines terms specific to the PACE benefit.

Section 460.2 Basis

    As stated in the 1999 interim final rule, the regulations set forth 
in 42 CFR part 460 are based on Sections 1894, 1905(a), and 1934 of the 
Act. Section 1894 of the Act authorizes Medicare payments to and 
coverage of benefits under PACE. Sections 1905(a) and 1934 of the Act 
authorize the establishment of PACE as an option under the State 
Medicaid plan to provide for Medicaid coverage of services furnished by 
the PACE program.
    No comments were received on this section.
    Final rule actions:
    This final rule will finalize Sec.  460.2 as published in the 1999 
interim final rule.

Section 460.4 Scope and Purpose

    We stated in the 1999 interim final rule that the purpose of the 
regulation was to set forth the requirements that an entity must meet 
in order to be approved as a PO under Medicare and Medicaid. It also 
sets forth how individuals may qualify to enroll in PACE, how Medicare 
and Medicaid payment will be made for PACE services, provisions for 
Federal and State monitoring of PACE programs, and procedures for 
sanctions and termination.
    We stated the purpose of a PACE program is to provide pre-paid, 
capitated, comprehensive health care services that are designed to:
     Enhance the quality of life and autonomy for frail, older 
adults;
     Maximize dignity of and respect for older adults;
     Enable frail, older adults to live in their homes and in 
the community as long as medically and socially feasible; and
     Preserve and support the older adult's family unit.
    This philosophy is based on Part I, section A, of the Protocol. 
Adopting a mission or philosophy statement that includes these elements 
indicates that an entity is guided by a set of values that influence 
its structure, planning, and day-to-day operations that is consistent 
with the purpose of PACE.
    No comments were received on this section.
    Final rule actions:
    This final rule will finalize Sec.  460.4 as published in the 1999 
interim final rule.

Section 460.6 Definitions

    This section of the 1999 interim final rule included the following 
definitions based on those in sections 1894(a) and 1934(a) of the Act 
and other terms determined necessary by CMS.
    Contract year means the term of a PACE program agreement, which is 
a calendar year, except that a PO's initial contract year may be from 
12 to 23 months, as determined by CMS.
    Medicare beneficiary means an individual who is entitled to 
Medicare Part A benefits or enrolled under Medicare Part B, or both.
    Medicaid participant means an individual determined eligible for 
Medicaid who is enrolled in a PACE program.
    Medicare participant means a Medicare beneficiary who is enrolled 
in a PACE program.
    PACE stands for Programs of All-inclusive Care for the Elderly.
    PACE center means a facility operated by a PO where primary care is 
furnished to participants.

[[Page 71250]]

    PACE organization (PO) means an entity that has in effect a PACE 
program agreement to operate a PACE program under this part.
    PACE program agreement means an agreement between a PO, CMS, and 
the State administering agency for the operation of a PACE program.
    Participant means an individual who is enrolled in a PACE program.
    Services include both items and services.
    State administering agency means the State agency responsible for 
administering the PACE program agreement.
    Trial period means the first 3 contract years in which a PO 
operates under a PACE program agreement, including any contract year 
during which the entity operated under a PACE demonstration program.
    In developing the definition of PACE organization, we explained in 
the 1999 interim final rule that sections 1894(a)(3) and 1934(a)(3) of 
the Act defined a ``PACE provider.'' We changed that term to ``PACE 
organization'' (PO) because we believed that the term ``PACE provider'' 
would be confusing. Medicare regulations (at 42 CFR 400.202) and 
Medicaid regulations (at 42 CFR 400.203) define the word ``provider,'' 
but the definitions are different and neither applies to entities that 
operate PACE programs. Those definitions denote individual providers of 
individual services under conventional fee-for-service systems. We 
selected the alternative term, PO, since ``organization'' is a term 
used in both titles XVIII and XIX when referring to managed care 
organizations, which are more similar to entities under PACE. In the 
few places where we use the term ``provider'' in this regulation, we 
are using it in the broad generic sense to refer to an individual or an 
entity that furnishes health care services. Our use of the term is not 
limited to the narrower Medicare definition in Sec.  400.202.
    Also, in defining contract year, we explained that a PO's initial 
(start-up) contract year may be from 12 to 23 months, as determined by 
CMS, to enable us to adjust the length of the initial (start-up) 
contract year so that subsequent years are on a standard annual 
calendar year cycle.
    Comment: One commenter suggested that we clarify the term 
``center'' by replacing it with the term ``PACE center.''
    Response: We agree and have replaced the term ``center'' with 
``PACE center'' throughout the regulation.
    Comment: We received several comments requesting that we clearly 
define PACE, what constitutes a PO, and what constitutes a PACE center 
including clarification that a PACE provider is considered a PACE 
program and may have more than one center.
    It was also recommended that we adopt the definition of PACE center 
as contained in the Protocol, which explicitly addresses the full range 
of services and benefits available at the PACE center.
    Response: In response to these comments, in this final rule, we are 
redefining ``PACE center'' to be more consistent with the definition 
provided in the Protocol and the statute by defining it as a facility 
which includes a primary care clinic, areas for therapeutic recreation, 
restorative therapies, socialization, personal care, and dining, and 
which serves as the focal point for coordination and provision of most 
PACE services.
    In addition, as noted below we are adding a definition of ``PACE 
program''. However, we disagree with the commenter who requested that 
we adopt the definition of ``PACE center'' as contained in the Protocol 
which explicitly identifies the full range of services and benefits 
available at the PACE center. We believe that our modification is more 
appropriate and less cumbersome than including every required service 
in the definition. We also believe that by expanding the definition of 
``PACE center'' that was published in the 1999 interim final rule, we 
are clarifying that a PACE center is a facility where most PACE 
services are provided, not just primary care.
    As noted earlier in this section, in the 1999 interim final rule, 
we defined PACE center as ``a facility operated by a PO where primary 
care is furnished to participants.'' This definition was based on 
section IV. B. 2 of the Protocol, which states: ``The PACE center is 
the focal point for coordination and provision of most PACE services. 
The PACE center is a facility which includes a primary care clinic, and 
areas for therapeutic recreation, restorative therapies, socialization, 
personal care and dining.'' The Protocol identified other requirements 
for a PACE center, which were included in other sections of the 1999 
interim final rule. Those requirements are included in the following 
sections: The list of required services is at Sec.  460.98; the 
requirement that POs operate at least one PACE center is in Sec.  
460.98(d)(1); the requirement that the frequency of attendance is 
determined by the IDT based on each participant's needs is at Sec.  
460.98(e); and the requirement that the PACE center is designed, 
equipped, and maintained to provide for the physical safety of 
participants, personnel, or visitors and to ensure a safe and sanitary 
environment is at Sec.  460.72.
    We believe the list of explicit services and benefits belongs in 
Sec.  460.98 which relates to ``Service delivery,'' and in Sec.  
460.72, which relates to ``Physical environment.''
    Comment: A commenter requested that we add a definition of a ``PACE 
program'' and use the following language ``all centers and service 
provision by an approved PACE provider in an approved service area.''
    Response: ``PACE program'' is defined in the Act at sections 
1894(a)(2) and 1934(a)(2) as an entity that meets the statutory 
requirements to be a PACE provider and provides comprehensive health 
care services to PACE program eligible individuals in accordance with 
the PACE program agreement and regulations. We have not included a 
definition for ``PACE program'' in our regulations at Sec.  460.6. 
However, we agree with the commenter that doing so would help to 
clarify and standardize PACE terminology. As noted above, we changed 
the term ``PACE provider'' to ``PACE organization'' and defined that 
term in the 1999 interim final rule.
    Based on sections 1894(a)(2) and 1934(a)(2) of the Act, we are 
defining a PACE program as a program of all-inclusive care for the 
elderly that is operated by an approved PACE organization and that 
provides comprehensive health care services to PACE enrollees in 
accordance with a PACE program agreement. As noted above, we are 
defining a PACE center as a facility which includes a primary care 
clinic, areas for therapeutic recreation, restorative therapies, 
socialization, personal care, and dining, and which serves as the focal 
point for coordination and provision of most PACE services. We do not 
think the commenter's language would be needed to ensure that PACE 
centers are included within the definition of a PACE program.
    Final rule actions:
    In this final rule we are:
     Replacing the term ``center'' with the term ``PACE 
center'' throughout the regulation.
     Redefining the term ``PACE center'' as ``a facility which 
includes a primary care clinic, areas for therapeutic recreation, 
restorative therapies, socialization, personal care, and dining, and 
which serves as the focal point for coordination and provision of most 
PACE services.''
     Defining ``PACE program'' to mean a program of all-
inclusive care for the elderly that is operated by an approved PACE 
organization and that provides

[[Page 71251]]

comprehensive health care services to PACE enrollees in accordance with 
a PACE program agreement.

Subpart B--PO Application and Waiver Process

Section 460.10 Purpose

    We established in the 1999 interim final rule, that this subpart 
sets forth application requirements for an entity that seeks approval 
from CMS as a PO. In the 2002 interim final rule, we amended Sec.  
460.10 to clarify that subpart B also establishes a process by which a 
PO may request a waiver of certain regulatory requirements in order to 
provide for reasonable flexibility in adapting the PACE service 
delivery model to the needs of particular organizations (such as those 
in rural areas).
PACE Under Both Medicare and Medicaid
    We require that each PO must enter into a program agreement under 
both sections 1894 and 1934 of the Act, that is, that each organization 
participate in both Medicare and Medicaid. Most of the text in those 
two sections is identical and our analysis indicates that key language 
contemplates entities acting as POs under both programs.
    Sections 1894(f)(2) and 1934(f)(2) of the Act require that we 
incorporate in our regulations the requirements applied to PACE 
demonstration programs under the PACE Protocol, to the extent 
consistent with the provisions of sections 1894 and 1934 of the Act. 
Under the Protocol, PACE demonstration programs operated under both 
Medicare and Medicaid. We believe that the directive to incorporate the 
requirements in the Protocol reflected an expectation by the Congress 
that all POs would participate in both Medicare and Medicaid. This view 
is reinforced by paragraph (f)(2)(B) of these sections, which permits 
us to modify or waive provisions of the PACE Protocol ``so long as such 
modification or waiver is not inconsistent with and would not impair 
the essential elements, objectives, and requirements'' of sections 1894 
and 1934 of the Act, but which forbids modifying or waiving, among 
others, the following provisions:
     Capitated, integrated financing that allows the 
organization to pool payments received from public and private programs 
and individuals; and
     The assumption by the organization of full financial risk.
    We concluded that both of these provisions preclude the possibility 
of a Medicare-only or Medicaid-only PACE program. For example, if a 
program could collect capitation payments from Medicare but bill fee-
for-service under Medicaid, not all financing would be capitated, nor 
would financing be integrated, nor would the organization assume full 
financial risk.
    However, the law does not require that States offer the PACE 
benefit under Medicaid. As indicated by its title, section 4802 of BBA 
provides for the ``Establishment of PACE Program as Medicaid State 
Option.'' If an entity attempted to become a PO under Medicare in a 
State which has not included PACE program services as an option under 
its Medicaid program, it would not be possible for that entity to be 
both a Medicare and a Medicaid PO. While this would curtail the 
availability of PACE programs in those States, we have concluded that 
this result was intended because a Medicare-only program could not meet 
the fundamental concept of an all-inclusive, integrated, capitated, 
full-risk program.
    Moreover, both sections 1894 and 1934 of the Act contemplate the 
active collaboration of Federal and State governments in the 
administration of PACE. Each State must have a SAA that is responsible 
for administering PACE program agreements in their State under sections 
1894 and 1934 of the Act. The SAA closely cooperates with CMS in 
establishing procedures for entering into, extending, and terminating 
PACE program agreements. The SAA cooperates with CMS and the PO in the 
development of participant health status and quality of life outcome 
measures. The SAA also cooperates with us in conducting oversight 
reviews of PACE programs and has the authority to terminate a PACE 
program agreement for cause. If Medicare-only programs had been 
contemplated in a State that does not elect the PACE option, there 
would have been no reason to assign such a significant role to an SAA. 
We believe that a State which has not chosen PACE as an optional 
service would be ill-prepared or unable to perform this role.
    As mentioned earlier, most of the text of section 1894 of the Act 
is identical to text in section 1934 of the Act. Portions of both text 
reflect the concept of entities acting as POs under both programs. The 
scope of Medicare PACE program benefits includes ``all items and 
services covered under this title (for individuals enrolled under this 
section [section 1894]) and all items and services covered under title 
XIX.'' Similarly, section 1934 of the Act, defines the Medicaid benefit 
package as ``all items and services covered under title XVIII (for 
individuals enrolled under section 1894) and all items and services 
covered under this title.'' In addition, to be eligible for PACE, an 
individual must require the nursing facility (NF) level of care covered 
under the State Medicaid plan.
    Section 1894(e) of the Act provides that ``CMS, in close 
cooperation with the SAA'' will establish program agreements for 
``entities that meet the requirements for a PO under this section, 
section 1934, and regulations.'' A corresponding provision is found at 
section 1934(e) of the Act, referring to ``entities that meet the 
requirements for a PO under this section, section 1894, and 
regulations.'' We believe that the use of the correlative ``and'' 
indicates that PACE entities would have to meet all three sets of 
requirements.
    A parallel provision provides for termination of PACE program 
agreements (see paragraphs (e)(5) of sections 1894 and 1934 of the 
Act). Termination of an agreement under both sections 1894 and 1934 of 
the Act may be accomplished by either ``CMS or a SAA.''
    Nonetheless, it is highly unlikely that any entity could be a 
viable PO without approval under both Medicare and Medicaid. The 
majority of potential participants are Medicare beneficiaries who also 
are eligible for Medicaid. Those who are not currently Medicaid-
eligible may eventually exhaust their financial resources and become 
eligible. Medicare participants who are not enrolled in PACE under 
Medicaid must pay premiums equal to the Medicaid capitation rate. Aside 
from the technicality that there would not be an established Medicaid 
capitation rate in a State that does not elect the PACE option, most of 
these participants would lack the ability to pay these significant 
premiums.
    As the above citations illustrate, some provisions of the law are 
conflicting and thus ambiguous. We therefore interpreted them to give 
effect to many of the provisions and policy objectives that they 
advance. Furthermore, in keeping with the congressional intent that the 
Protocol guide our implementation of the PACE program, we determined 
that POs must be approved under both Medicare and Medicaid.
    Based on this interpretation, if a State should choose not to amend 
its State Medicaid plan to adopt PACE as an optional Medicaid service, 
we would not accept PACE applications from entities in that State. 
Also, if a State has elected the optional benefit but declines to 
recommend a particular entity as a PO, we would not accept an 
application from that entity.

[[Page 71252]]

    We stated in the 2002 interim final rule that to implement section 
903 of BIPA, we amended the PACE regulation by adding Sec.  460.26 and 
Sec.  460.28 to establish a process for a PO to request waiver of 
regulatory requirements. This process allows for variations while 
achieving the intent of the regulatory provision and responding to the 
needs of POs to develop and expand within their States' long-term care 
delivery system.
    Waivers will be discussed in detail under Sec.  460.26 and Sec.  
460.28.
    Comment: Another commenter recommended that social support services 
and participant care be more clearly defined so beneficiaries and 
caregivers may make informed decisions about the type and level of care 
to be provided.
    Response: In response to the comment regarding a more defined 
regulation where social services and participant care is concerned, we 
disagree with this commenter, as required services are participant 
specific. After the IDT determines a participant requires a service and 
it is included in their plan of care, those services become required 
for that participant for that specific need. Therefore, it would not 
truly represent the PACE model to constrain the benefit by defining it 
in regulatory language.
    Final rule actions:
    This final rule will finalize Sec.  460.10, as published in the 
2002 interim final rule.

Section 460.12 Application Requirements

    We established Sec.  460.12 to set forth the application 
requirements for the PACE program. In order for CMS to determine 
whether an entity qualifies as a PO, an individual authorized to act 
for the entity must submit an application that describes thoroughly how 
the entity meets all the requirements specified in this regulation. In 
recognition of the 90-day review timeframe specified in the statute and 
described below and the numerical limit on the number of PACE program 
agreements, we will review and take action to approve, deny, or request 
additional information only on complete applications; those 
applications that address all elements of the PACE program agreement. 
We will send a letter to each applicant indicating whether or not the 
application is complete and specifying when the 90-day review period 
ends.
    We require in Sec.  460.12(b) that applications for PO status be 
accompanied by an assurance from the SAA indicating that it considers 
the entity to be qualified to be a PO and that the State is willing to 
enter into a PACE program agreement with the entity. We will not accept 
applications from entities that have not obtained these assurances.
    To enable a SAA to make these assurances, an entity would have 
established to the satisfaction of the State that it is committed to 
the PACE model of care, that there is sufficient funding for program 
development and facilities, that there is adequate demand for PACE 
services as shown by demographic analysis.
    Entities that are interested in developing a PACE program agreement 
should contact their SAA to determine whether the State has submitted 
or plans to submit a SPA to elect PACE as an optional benefit under its 
State Medicaid plan and if the State has established additional 
requirements for POs. Section 1905(a)(26) of the Act provides authority 
for States to elect PACE as an optional Medicaid benefit. The State 
plan electing the optional PACE program must be approved before we can 
approve an application for a PO in that State. We received three 
comments related to application requirements.
    Comment: Commenters questioned the requirement that POs must be 
approved by their SAA. Further, they requested that we specify an 
absolute role for SAA, and revise the regulatory language to reflect 
the SAAs' responsibility to submit the program application and the 
States' role in the application process.
    Response: As we explained in the 1999 interim final rule, States 
have played a significant role in the development of the PACE 
demonstration program as well as other community-based alternatives to 
institutionalization. Most States have implemented home and community 
based programs that provide comprehensive coordinated services to 
various groups of Medicaid recipients. As a result, States have gained 
extensive experience in demographic analysis and contracting with 
entities that are capable of delivering a specified range of services.
    Although the PACE statute does not specify the States' role in the 
application approval process, many aspects of implementing PACE in 
Medicare and Medicaid will necessitate extensive involvement of the 
SAAs and the State Medicaid Agencies. The State must elect to provide 
PACE services as an option under the Medicaid State plan and PACE 
applications must be accompanied by an assurance from the SAA that the 
State considers the entity to be qualified to be a PO and is willing to 
enter into a program agreement with them.
    With regard to applications, we continue to believe the States are 
in the best position to work with potential organizations to develop 
programs that meet our requirements and are integrated into the States' 
overall long-term care delivery system.
    Comment: One commenter asked us to clarify the regulatory provision 
related to the hiring requirements of non-operational programs before 
submission of their program application. The commenter stated that it 
is unreasonable to expect the applicant would have hired core staff 
before application submission.
    Response: Although hiring requirements for non-operational PACE 
programs do not appear in our regulations at Sec.  460.12, we addressed 
these requirements in the preamble of the 1999 interim final rule (64 
FR 66238). We stated, ``To enable a State to make such assurances, an 
entity would have established to the satisfaction of the State that it 
is committed to the PACE model of care, that there is sufficient 
funding for program development and facilities, that there is adequate 
demand for PACE services as shown by demographic analysis, and that the 
entity has hired core PACE staff and has developed contracts for 
referral arrangements and other program services that the site will not 
furnish directly.''
    When the 1999 interim final rule was developed, there were several 
PACE demonstration programs that needed to transition to permanent 
provider status. As they were operational and had key staff members in 
place before submitting their PACE provider applications, this 
requirement was not an issue.
    However, as all PACE demonstration programs have transitioned to 
permanent provider status, applications will now be primarily from non-
operational providers. We acknowledge that start-up costs are extensive 
and paying salaries for top management staff without a revenue stream 
is unrealistic. We do not believe that it is appropriate to hold non-
operational applicants to the same standard as POs that had been fully 
operational under the PACE demonstration program. Therefore, we are not 
requiring that core staff be hired before application approval. 
However, at the time of an organization's Readiness Review, we do 
expect documentation that core staff have been chosen and accepted 
those specific key positions. Language related to staff contracts of 
non-operational organizations has been included on page ix of the 
Provider Application, which

[[Page 71253]]

can be found on the PACE Web site under Provider Application and 
Appendices at http://www.cms.hhs.gov/pace/. This signed certification 

guarantees us, among other things, that the SAA will verify that the PO 
has qualified staff employed or under contract before furnishing 
services. This document must be signed by the SAA and included as part 
the PACE provider application.
    In the 2002 interim final rule, we revised Sec.  460.12 by removing 
and reserving paragraph (a)(2) to clarify that although we may begin 
review of PO applications, we may sign a program agreement only with a 
PO located in a State with an approved SPA electing PACE as an optional 
benefit under its Medicaid State plan. We are finalizing this provision 
by deleting Sec.  460.12(a)(2) entirely. For the sake of continuity we 
are redesignating Sec.  460.12(a)(3) as Sec.  460.12(a)(2).
    Final rule actions:
    In this final rule we are redesignating Sec.  460.12(a)(3) to Sec.  
460.12(a)(2).

Section 460.14 Priority Consideration

    Section 4803(c) of the BBA directed us to give priority in 
processing applications, during the 3-year period following enactment 
of the BBA on August 5, 1997, to PACE demonstration programs and then 
to entities which had applied to operate a PACE demonstration program 
as of May 1, 1997.
    In the 1999 interim final rule, we established Sec.  460.14 to 
address priority applications and stated that to give priority in 
processing applications from entities that met the criteria, we would 
accept applications only from those entities beginning on the effective 
date of the 1999 interim final rule and continuing for 45 days. 
Applications from other entities would not be accepted during this 
period. Moreover, during the subsequent 45 days, extending to 90 days 
after the effective date of that regulation, we stated we would 
continue to accept applications from entities that met the priority 
processing criteria and we would also accept applications from entities 
that qualify for special consideration as described in the following 
section.
    We did not receive any requests for priority consideration.
    Comments related to Sec.  460.14 also address Sec.  460.16 and will 
be addressed at the end of Sec.  460.16.

Section 460.16 Special Consideration

    Section 4803(c) of the BBA required that we give special 
consideration in the processing of applications during the 3 years 
following enactment, to any entity that, as of May 1, 1997, had 
indicated specific intent to become a PO through formal activities such 
as entering into contracts for feasibility studies.
    In Sec.  460.16, we established a process for special consideration 
of a PACE application. Similar to the process for priority 
consideration, to give special consideration in processing applications 
from entities that meet the criteria in the 1999 interim final rule, we 
indicated we would accept applications from these entities beginning 45 
days after the effective date of the 1999 interim final regulation. We 
further noted that during the 45-day period that extends from 45 days 
after the effective date to 90 days after the effective date, we would 
accept applications only from entities that met the priority processing 
criteria or entities that qualified for special consideration. 
Applications from other entities would not be accepted during this 
period.
    Applications from entities that believed they were entitled to 
special consideration were to include information regarding the formal 
activities they were engaged in towards becoming a PO. If we agreed 
that special consideration was appropriate for applications submitted 
after the special 45-day window, we would identify those applicants and 
factor in the entity's special status in the event that we had a 
greater number of applications under review than available capacity for 
PACE program agreements.
    We did not receive any requests for special consideration.
    Comment: Six commenters requested clarification regarding the 
criteria and process applied to applications under the BBA mandate 
providing priority and special consideration in processing PACE 
applications.
    Response: We believe the 2002 interim final rule provided 
sufficient information as to the criteria and process needed for 
priority and special consideration for PACE applications. More 
importantly, however, we note that as the authority to provide these 
considerations expired on August 5, 2000, it is no longer necessary to 
retain these regulations.
    Final rule actions:
    In this final rule we are deleting Sec.  460.14 and Sec.  460.16.

Section 460.18 CMS Evaluation of Applications

    We established the information used to evaluate a PO application in 
the 1999 interim final rule. We approve entities based upon a review of 
the materials submitted as part of the application, as well as 
information obtained from the SAA or through onsite visits.
    No comments were received on Sec.  460.18.
    Final rule actions:
    This final rule will finalize Sec.  460.18 as published in the 1999 
interim final rule.

Section 460.20 Notice of CMS Determination

    Sections 1894(e)(8) and 1934(e)(8) of the Act require us to approve 
or deny an application for PO status within 90 days after the date of 
the submission of the application unless additional information is 
requested. Applications are deemed approved unless we deny PO status in 
writing or request additional information within the 90-day timeframe. 
In the 1999 interim final rule, we established procedures for 
implementing these requirements at Sec.  460.20. We clarified that, for 
purposes of the 90-day time limit described in this section, the date 
that an application is considered to be submitted to CMS is the date on 
which the application is delivered to the address designated by CMS.
    These statutory sections also provide that we may request in 
writing additional information as may be required in order to make a 
final determination regarding the application and, after the date we 
receive that information, the application shall be deemed approved 
unless, within 90 days of that date, we deny the request.
    Based on this authority, we may take up to 90 days to request 
additional information and, once the information is received, may take 
an additional 90 days to complete processing of the application. It is 
important to note that there is no corresponding requirement that the 
SAA or the PO respond to our request for additional information (RAI) 
within a specified timeframe.
    If the additional information proves insufficient to approve the 
application, the application will be denied. We will notify each 
applicant of our determination and the basis for the determination in 
writing. If the application is denied, we will provide the basis for 
the denial and the process for requesting reconsideration of the 
application.
    No comments were received on Sec.  460.20.
    Final rule actions:
    This final rule will finalize Sec.  460.20 as published in the 1999 
interim final rule.

Section 460.22 Service Area Designation

    Sections 1894(e)(2(B) and 1934(e)(2)(B) of the Act permit the 
Secretary, in consultation with the SAA, to exclude from a service area 
designation an area that is already

[[Page 71254]]

covered under another PACE program agreement. In the 1999 interim final 
rule, we specified in Sec.  460.22 that each applicant must designate 
the service area of the program. We stated that CMS (in consultation 
with the SAA) may exclude from the proposed service area designation 
any area that is already covered under another PACE program agreement. 
Consistent with the statute, we believe this was required to avoid 
unnecessary duplication of services and impairing the financial and 
service viability of an existing PO.
    No comments were received on Sec.  460.22.
    Final rule actions:
    This final rule will finalize Sec.  460.22 as published in the 1999 
interim final rule.

Section 460.24 Limit on Number of PACE Program Agreements

    This provision implements sections 1894(e)(1)(B) and 1934(e)(1)(B) 
of the Act establishing a limit on the number of PACE program 
agreements that may be in effect on August 5 of each year, that is, the 
anniversary of the enactment of the PACE statute. Those sections state 
that we shall not permit the number of POs with which agreements are in 
effect under those sections or PACE demonstration programs under 
section 9412(b) of the OBRA of 1986 to exceed--
     Forty as of August 5, 1997, the date of the enactment of 
the PACE statute, or
     As of each succeeding anniversary of that date, the 
numerical limitation for the preceding year plus 20. The annual 
increase in the number of PACE program agreements is not tied to the 
actual number of agreements in effect as of a previous anniversary 
date.
    Based on this statutory language, we may enter into up to 80 PACE 
program agreements as of August 5, 1999, and the limit on the number of 
PACE program agreements increases by 20 each year thereafter.
    No comments were received on Sec.  460.24.
    Final rule actions:
    This final rule will finalize Sec.  460.24 as published in the 1999 
interim final rule.

Section 460.26 Submission and Evaluation of Waiver Requests

Section 460.28 Notice of CMS Determination on Waiver Requests

    These sections were established in the 2002 interim final rule to 
implement section 903 of BIPA. As we explained in that rule, we 
considered amending the 1999 interim final rule to identify each 
requirement that is eligible for waiver and provide separate waiver 
criteria for each requirement. However, we were concerned that amending 
the regulation for each waiver would: (1) Create a regulatory level of 
specificity that might make it difficult to apply to future requests 
for similar but not identical waivers; and (2) cause a significant 
delay between when the need for a waiver is identified and when it may 
be implemented.
    As an alternative, we amended the PACE regulation by adding Sec.  
460.26 and Sec.  460.28 to establish a process for a PO to request 
waiver of regulatory requirements.
    As noted previously, the PACE Protocol and the 1999 interim final 
rule have been proven effective as POs grow and reach financial 
solvency. We have learned a great deal about variations in the model 
through the information we received in processing grandfathering 
requests under section 902 of BIPA and numerous discussions with the 
National PACE Association (NPA), POs, and States. Allowing for waivers 
provides a unique opportunity for POs, the States, and CMS to 
experiment with new approaches within the structure of the PACE model. 
This process allows for variations while achieving the intent of the 
regulatory provision and responding to the needs of POs to develop and 
expand their States' long term care delivery system. The POs will serve 
as an ongoing laboratory that over time will establish best practices 
that may ultimately replace the current regulatory requirements.
    We realize that in order to foster innovation and creativity within 
the PACE program, POs must be granted some degree of flexibility in 
their operation and service delivery. However, we must balance this 
need for flexibility with our responsibility to ensure quality, cost 
effective care for all beneficiaries.
    Based upon our experience and review of grandfathering requests 
under section 902 of BIPA, we established two types of waivers in the 
2002 interim final rule, that is, general waivers and conditional 
waivers subject to evaluation. We discuss the waiver types below:
1. General Waivers
    A general waiver may be granted to a PO that has successfully 
implemented a specific operating arrangement, for example, an operating 
arrangement approved under section 902 of BIPA. General waivers 
continue indefinitely; however, approval may be withdrawn for good 
cause if periodic monitoring of the organization's operations and 
policies indicates participant care is being jeopardized, there is 
fiscal instability, or the goals of the PACE model are not maintained.
2. Conditional Waivers
    A conditional waiver, subject to evaluation, is a provisional 
waiver we would approve for a specific period of time to a new or 
experienced organization. During the conditional period, the PO would 
need to submit specific data, that we prescribed, that would allow us 
to monitor and evaluate the conditional waiver to determine whether the 
waiver may become permanent. This category of waiver may include the 
following scenarios:
    (a) A request for waiver without which a PO would be prevented from 
entering the program. For example, if a prospective PO has been unable 
to hire or contract with a social worker with a Master's degree, we may 
consider approving a conditional waiver request to allow a social 
worker with a baccalaureate degree to operate in this capacity until a 
qualified social worker is hired. This waiver would only be in effect 
until the PO could hire or contract for an appropriate staff member.
    (b) A request for approval of an arrangement with which a PO does 
not have any experience. We want to encourage creative approaches to 
improving the PACE model and view conditional waivers as a responsible 
way to balance the need of a PO with protection of participant health 
and safety. We need to be cautious in approving arrangements in which 
the PO does not have a proven record of success. In approving a 
conditional waiver request, we may limit the number of participants 
exposed to the waiver or approve the waiver for a limited period of 
time or at a specific PACE center until we are assured through 
evaluation that (1) the intent of the regulation is met; and (2) the 
approach is not inconsistent with nor impairs the essential elements, 
objectives, and requirements of PACE. At that time, we may approve a 
general waiver so that the PO may expand the arrangement to other PACE 
centers it manages without jeopardizing participant care.
    Each of the conditional waivers is subject to periodic monitoring. 
A PO approved for a conditional waiver must submit any prescribed data 
at specified intervals. We have learned that, in most cases, conducting 
a detailed review of a waiver request allows us to implement waiver 
approvals without having to require data submission. This evaluation 
serves a dual purpose. It allows us to monitor the impact on 
participant care as well as enable us to determine if any permanent 
changes to

[[Page 71255]]

PACE should be implemented through regulations. In addition, it allows 
us to provide technical assistance to other POs requesting a similar 
waiver.
    In the 2002 interim final rule, we discussed the process necessary 
to obtain any waiver. To obtain either a conditional or general waiver, 
a PO must provide a detailed description of how its proposed 
modification differs from the regulatory requirement and how it meets 
the intent of the regulatory provision. The burden is on the PO to 
explain why a waiver is needed to start up or expand their program. 
Where a PO has not completed the trial period, attained financial 
solvency, and demonstrated competence with the PACE model as evidenced 
by successful CMS and State onsite reviews and monitoring activities, 
it will be necessary for the organization to explain how the waiver is 
necessary to meet those objectives. For a new organization, it will be 
necessary for the organization to explain why a waiver is needed for 
the organization to begin serving participants.
    Consistent with the process developed for initial PACE provider 
applications, all waiver requests must be submitted to the SAA for 
initial review. The SAA forwards the waiver request to CMS along with 
any concerns or conditions they may have regarding the waiver. We will 
not accept waiver requests directly from POs. Waiver requests submitted 
with an initial application process must be prepared as a separate 
document. These requests are reviewed simultaneously and in conjunction 
with the application. Where an existing PO is requesting a waiver, the 
request must be submitted through the State to the CMS address for BIPA 
903 waiver requests indicated on the PACE home page (http://www.cms.hhs.gov/PACE
). We intend to process waiver requests as 

expeditiously as possible in order to be responsive to the needs of new 
organizations to develop their programs and to the needs of mature 
organizations as they expand.
    Section 903 of BIPA directs us to approve or deny a request for a 
modification or waiver no later than 90 days after the date of receipt. 
We clarified in Sec.  460.28(b) that the date of receipt is the date 
the request is delivered to the address designated by CMS. We note that 
there is no statutory authority to stop the 90-day clock if additional 
information is necessary to make a determination on a waiver request. 
Thus, it is in the PO's best interest to provide all pertinent 
information relevant to their request. Where additional information is 
necessary, the CMS PACE Team Leader will inform the PO as early as 
possible in the review process. The PO will then be responsible for 
submitting the additional information in a timely enough manner to 
allow us to evaluate the additional information and make a 
determination on the waiver request within the allotted 90 days. If the 
reply from the PO is not received in a timely manner, we would have to 
deny the request. The PO may then reapply for the waiver, starting a 
new 90-day clock.
    Consistent with sections 1894(f)(2)(B) and 1934(f)(2)(B) of the 
Act, we specified in Sec.  460.26(c) the following requirements that 
would not be waived:
    (1) A focus on frail elderly qualifying individuals who require the 
level of care provided in a nursing facility;
    (2) The delivery of comprehensive, integrated acute and long-term 
care services;
    (3) The IDT approach to care management and service delivery;
    (4) Capitated, integrated financing that allows the provider to 
pool payments received from public and private programs and 
individuals; and
    (5) The assumption by the provider of full financial risk (we note 
that assuming full financial risk does not preclude an organization 
from utilizing reinsurance, stop-loss protection, or other mechanism to 
meet its financial obligations).
    In addition to these five provisions, we will not grant waivers 
that we believe are inconsistent with or would impair the essential 
elements, objectives, and requirements of sections 1894 and 1934 of the 
Act.
    In addition to the requirements specified in sections 1894(f)(2)(B) 
and 1934(f)(2)(B) of the Act, we believe there are other requirements 
that must not be waived. For example, health care is focused at a PACE 
center; the IDT is composed of certain health care professionals that 
manage all of the health care provided to participants; a comprehensive 
assessment by the IDT is conducted before admission into the PACE 
program; and reassessment occurs at least every 6 months or whenever 
there is a significant change in a participant's health status. 
Further, we believe that PACE participants are entitled to the same 
patient rights' protection available in the Medicare or Medicaid fee-
for-service or managed care programs. Therefore, we will not approve 
waiver or significant modification of these requirements.
    Two waiver issues specifically mentioned in section 903 of BIPA are 
requirements related to employment and the use of community-based 
primary care physicians (PCP). In this approach, the PCPs work out of 
their offices rather than from the PACE center and do not primarily 
serve PACE participants.
    The 2002 interim final rule removed the restrictive waiver 
provisions at Sec.  460.68(c) regarding direct or indirect interest in 
contracts, which was limited to rural and Tribal organizations. In 
addition, the 2002 interim final rule also removed the two waivers in 
Sec.  460.102(g) related to employment of the PCP and the requirement 
that the IDT primarily serve PACE participants. These waivers were 
available if CMS and the SAA determined that there was ``insufficient 
availability in the PO's service area of individuals who meet the 
requirement, or State licensing laws make it inappropriate for the 
organization to employ physicians.'' Although we deleted the specific 
waivers that were intended to encourage development of PACE in rural or 
Tribal or other medically underserved areas, we continue to recognize 
the special need for flexibility in these areas and remain committed to 
allowing waivers to promote PACE in medically underserved areas. 
Deletion of the specific waiver language was intended to provide 
greater flexibility within the overall PACE regulatory structure. We 
remain committed to working with rural and Tribal communities to help 
them address the challenges of developing successful PACE programs. 
Organizations that seek waiver of these or any other regulatory 
requirements must follow the requirements specified in Sec.  460.26.
    We note that a PO requesting a waiver of the prohibition on direct 
or indirect interest in contracts must develop policies and procedures 
for disclosure of financial interest to the governing body, establish 
recusal restrictions, and a process to record recusal actions for 
review by CMS and the SAA in its waiver request.
    Comment: We received two comments expressing concern about 
compromising the integrity of the PACE model by providing expanded 
flexibility.
    One commenter offered assistance in evaluating PACE policy, 
program, and practice on a continuing basis. The second commenter was 
concerned that the PACE regulations lack sufficient safeguards to 
preserve the model as established by the Protocol. The commenter 
indicated that maintaining the PACE center as the focal point for 
delivery of services and retaining the central role of the IDT in 
managing the health care and other services provided to PACE 
participants were critical to the PACE model. The commenter also 
emphasized the important role of the PCP in the Protocol, stating, 
``the

[[Page 71256]]

ultimate responsibility for managing participant medical care rests 
with the PCP; therefore, if this team member is not present during team 
meetings the ability to fulfill this obligation will be compromised.''
    Response: We share the commenter's concerns regarding the integrity 
of the PACE model, and thank the commenter who offered assistance in 
evaluating the PACE program. We believe the flexibility permitted by 
the 2002 interim final rule has sufficient safeguards to ensure the 
integrity of the model. We instituted contracting and oversight 
requirements we believe will ensure quality of care for PACE 
participants. During the development of the 2002 interim final rule, we 
made a concerted effort to develop a waiver process that would allow 
modification of the model without excessive controls, while at the same 
time not being too burdensome for POs. We believe we achieved that 
balance.
    The PACE model has been proven successful when the PACE center is 
the focal point for delivery of services and when the IDT's central 
role of managing the health care and other services provided to PACE 
participants is retained. Therefore, we believe there are few 
circumstances when it would be appropriate to waive these elements of 
the PACE model without substantial justification by a PO or potential 
PO, for example, the entity being a rural or Tribal organization. 
However, according to sections 1894(f)(2)(B) and 1934(f)(2)(B) of the 
Act, we do not have the authority to waive the provision requiring the 
IDT's central role managing the health care and other services provided 
to PACE participants, since it is statutorily mandated.
    Although we have permitted the use of community-based PCPs, we 
require that effective and consistent communication be maintained. 
Whenever we have received a request for waiver pertaining to use of 
community-based PCPs, the PO has had to provide in-depth justification 
and meet our conditions for waiver. Among other conditions for waiver 
approval, the community-based PCP must perform all the requirements of 
the staff PCP including but not limited to participation in IDT 
meetings related to their participants' participation in Quality 
Assurance and Performance Improvement (QAPI) activities and agree to PO 
oversight by the medical director.
    Comment: One commenter submitted comments related to the submission 
and evaluation of waiver requests. This commenter supported reasonable 
waiver requests for community-based PCPs for flexibility and innovation 
within PACE which will allow the program to grow. The commenter also 
supported conditional waivers, which would allow CMS to monitor the 
performance of organizations utilizing community-based PCPs as well as 
participant outcomes. The commenter recommended that we focus on 
processes for integrating care while utilizing community-based PCPs.
    Response: In general, we are not inclined to approve waiver 
requests allowing POs to utilize community-based PCPs without 
identifying a substantial need. However, we believe there are 
circumstances when the use of community-based PCPs may be appropriate. 
For example, it is important for a participant to have a physician that 
speaks their language and understands their culture's mores and 
traditions, which can improve participant compliance with their plans 
of care and, therefore, their health outcomes. We have approved a 
limited number of waiver requests allowing community-based PCPs 
contingent on their compliance with specific requirements. We plan to 
monitor and review the impact of the interactions between the 
community-based PCPs and the IDT and participant care before we alter 
the conditions currently applied to these waiver requests.
    Comment: Commenters asked whether PACE programs which are operating 
under grandfathering arrangements would be required to request a waiver 
in order to continue operations. They believe having to request waiver 
of operational arrangements grandfathered under BIPA 902 will be 
administratively burdensome, and they recommend POs be allowed to 
expand grandfathering arrangements ``organization wide'' provided the 
expansion is ``* * * reasonably consistent with the objectives of the 
PACE program.'' They suggested the PO could file a notice with CMS 
describing the expansion arrangement and how it is consistent with 
program objectives.
    Response: PACE demonstration program sites were granted BIPA 902 
``grandfathering'' of certain operational arrangements that did not 
meet the 1999 interim final rule, if the identified practice was in 
place before July 1, 2000. As the approved ``grandfathering'' was 
effective, only to the extent it existed on July 1, 2000, we believe it 
was not intended to cover a new or expanded site. As a result, POs need 
to submit BIPA 903 waiver requests of grandfathered practices for 
expansion sites.
    Based on our experience with the waiver process, we believe there 
is value in CMS and SAA review and approval of waivers. The 
consultations involved in the waiver process allows CMS and the SAA to 
discuss the PO's ability to implement the requested waiver, any 
concerns either agency has regarding the waiver request, request 
further information or clarification of the PO's operations, and 
determine any requirements or conditions that will be included in the 
waiver approval. CMS and the SAA collaborate in the review and approval 
of waivers. We have found that the SAA generally has a better knowledge 
and understanding of the PO and its operations and relevant State laws 
and requirements.
    Comment: One commenter indicated that the regulatory language fails 
to address entities that are not already a PO, saying that prospective 
POs (as well as established POs) should be eligible for waivers of 
regulatory requirements. The commenter requested clarification 
regarding whether PACE demonstration programs transitioning to 
permanent provider status, pre-PACE programs, and previously ``non-
operational'' entities are eligible to request waivers of regulatory 
requirements.
    Response: Any entity submitting a PACE provider application may 
submit a request for waiver. The PO demonstration programs had been 
operating in some cases for years and the implementation of the 1999 
interim final rule could have disrupted operations and care to the 
participants as the demonstration programs transitioned to permanent 
provider status and were required to be in compliance with the 1999 
interim final rule. BIPA provided flexibility for those transitioning 
demonstration programs to continue their existing operational 
arrangements and a waiver process for those organizations that did not 
meet the grandfathering criteria but were unable to comply with the 
1999 interim final rule. We believe the intent of the waiver provision 
in BIPA was to assist organizations to participate in the Medicare and 
Medicaid PACE benefit program.
    We believe that there may be circumstances when applicants are not 
able to comply with the regulations. The BIPA section 903 waiver 
process allows developing organizations to work with CMS and the SAA to 
develop an appropriate alternative rather than abandon their efforts to 
become a PACE program when they discover they can not meet the 
regulatory requirements. Therefore, we have allowed these entities to 
submit waiver requests. A waiver request must be submitted as a

[[Page 71257]]

separate document from the provider application and must contain 
substantial justification for the request. Pre-PACE organizations are 
Medicaid pre-paid health plans that provide Medicare services under 
Medicare fee-for-service rules and certain Medicaid services paid by 
Medicaid on a capitated basis. These organizations may submit a waiver 
request and their PACE provider application simultaneously but as 
separate documents.
    We will accept waiver requests from non-operational entities and 
pre-PACE applicants, in an attempt to assist new organizations that 
would otherwise be unable to meet regulatory requirements. All waiver 
requests must be submitted through the SAA, who will review and forward 
to CMS. Regardless of the prior status of the entity, a request for a 
waiver is reviewed on a case-by-case basis.
    Comment: Commenters also requested that we make information 
regarding approved waiver requests available to current and potential 
POs.
    Response: At this time, we do not agree that making information on 
particular PACE programs available is warranted. We believe it would be 
more beneficial for each PO to develop their own unique waiver request 
and rationale. Each PO is a unique operational entity that has specific 
circumstances and experience that influence the appropriateness for 
approving a waiver. Therefore, approving all similar requests for a 
waiver of a specific requirement is inappropriate. Our intention is 
that all POs comply with the PACE regulations.
    Final rule actions:
    In this final rule, we are expanding the regulatory requirements of 
Sec.  460.26 to permit POs and entities applying to become POs to 
submit waiver requests.

Section 460.28 Notice of CMS Determination on Waiver Requests

    Comment: One commenter requested clarification as to whether an 
entity submitting a PACE application is permitted to submit a waiver 
request separate from the provider application, as prompt CMS 
determination will be important to the organization's ability to move 
forward with PACE development. The commenter also asked whether the CMS 
timeframe for responding to waiver requests is affected by the status 
of the request, or whether the applicant is an operational or a 
prospective PO.
    Response: Waiver requests may accompany an application, but must be 
prepared and submitted as a separate document. Requests will be 
reviewed simultaneously and in conjunction with the application. 
Alternatively, waiver requests can be submitted independently of the 
application by POs that are currently operational.
    The timeframe for our response to a waiver request is the same 
regardless of the operational status of the requestor. We have a 
statutory 90-day timeframe to approve or deny waiver requests. As a 
result, when we request additional information, regarding a waiver 
request, it is incumbent upon the organization to respond as 
expeditiously as possible to provide CMS and the SAA time to review 
their responses. We provide a written approval or denial letter to the 
PO or PACE applicant with the determination and any additional 
conditions.
    Final rule actions:
    In this final rule, we are amending paragraph (a)(2) by adding ``or 
PACE applicant,'' thereby requiring CMS to notify the PO or PACE 
applicant in writing of the decision to deny the submitted waiver 
request.

Subpart C--PACE Program Agreement

    The purpose of subpart C is to establish requirements for the PACE 
program agreement establishing the entity as a provider of PACE 
benefits under Medicare and the Medicaid State plan.

Section 460.30 Program Agreement Requirements

    In accordance with sections 1894(a)(4) and 1934(a)(4) of the Act, 
we established Sec.  460.30 to require that each PO have an agreement 
with CMS and the SAA for the operation of a PACE program by the 
organization under Medicare and Medicaid. This three-party agreement 
must be signed by an authorized official of the organization, as well 
as by an authorized CMS official and an authorized State official.
    We received no public comments on Sec.  460.30 of the 1999 interim 
final rule.
    In the 2002 interim final rule, we revised the regulatory language 
to reflect that the PACE program agreement is a three-party agreement 
that is signed by CMS, the SAA, and the PO. Also, we added regulatory 
language to clarify that CMS may sign a program agreement only with a 
PO that is located in a State with an approved SPA electing PACE as an 
optional benefit under its Medicaid State plan.
    We received no comments on this section of the 2002 interim final 
rule.
    Final rule actions:
    This final rule will finalize Sec.  460.30 as published in the 1999 
and 2002 interim final rules.

Section 460.32 Content and Terms of PACE Program Agreement

    In Sec.  460.32(a), we stipulate the required content of a PACE 
program agreement.
    We require that each PACE program agreement designate the service 
area of the program, specifically identifying the area by county, zip 
code, street boundaries, census tract, block, or tribal jurisdictional 
area, to the extent that those identifiers are appropriate. Any changes 
in the designated service area would require advance approval by CMS 
and the SAA. This requirement implements the provisions of sections 
1894(e)(2)(A)(i) and 1934(e)(2)(A)(i) of the Act and reflects Part I, 
section D of the Protocol.
    Each PO must agree to meet all applicable requirements under 
Federal, State, and local laws and regulations, including provisions of 
the Civil Rights Act, the Age Discrimination Act, and the Americans 
with Disabilities Act. These requirements include, but are not limited 
to, all requirements contained in the regulations implementing those 
Acts. This requirement implements in part the provisions of sections 
1894(e)(2)(A)(iv) and 1934(e)(2)(A)(iv) of the Act.
    We require that the program agreement indicate the effective date 
and term of the agreement as well as information related to: 
Organizational structure of the PO; participant rights; processes for 
grievances and appeals; eligibility; enrollment and disenrollment 
policies; service description; QAPI; capitation rates; names and 
numbers of administrative contacts in the organization; and program 
agreement termination procedures. These requirements are based on 
sections 1894(b)(2) and 1934(b)(2) of the Act and on Part X, section A 
of the Protocol.
    Each PACE program agreement includes a statement of the levels of 
performance that we require the organization to achieve on standard 
quality measures and the data and information on participant care that 
CMS and the State require the organization to collect. A detailed 
discussion of the levels of performance and the standard quality 
measures are contained in the preamble discussions for Sec.  460.134 
and Sec.  460.202(b) in the 1999 interim final rule.
    In Sec.  460.32(b), we specify that a PACE program agreement may 
provide additional requirements for individuals to qualify as PACE 
program eligible individuals. This provision implements sections 
1894(e)(2)(A)(ii) and 1934(e)(2)(A)(ii) of the Act. However,

[[Page 71258]]

the eligibility criteria in Sec.  460.150(b)(1)-(3) cannot be modified. 
In addition, a PACE program agreement may contain additional terms and 
conditions as the parties agree to, if the terms and conditions are 
consistent with sections 1894 and 1934 of the Act and with these 
regulations. This provision implements sections 1894(e)(2)(A)(v) and 
1934(e)(2)(A)(v) of the Act.
    We received five comments on the 1999 interim final rule related to 
the program agreement, which are listed below.
    Comment: One commenter requested that we clarify whether the 
program agreement content is meant as a substitute for all provisions 
or only some of the provisions of the State Medicaid contract 
requirements in 42 CFR part 434. The commenter also asked whether 
additional terms and conditions could be included in the PACE program 
agreement to meet specific State law requirements.
    Response: The PACE program agreement is a three-way contract 
between the PO, the SAA and CMS, and contains the PACE requirements 
from the Federal statute and regulations. If the SAA has requirements 
beyond those in the three-way PACE program agreement, those 
requirements should be addressed in a separate contract between the 
State and the PO. The PACE three-way program agreement can be an 
attachment to the State-PO contract. As we stated above, each PO must 
agree to meet all applicable requirements under Federal, State, and 
local laws and regulations.
    States may implement additional or more stringent requirements if 
they are consistent with sections 1894 and 1934 of the Act and with 
Federal laws and regulations. However, if there is a conflict between 
the State and Federal requirements, the Federal requirements would 
generally take precedence.
    Comment: We were asked to describe the mechanism for revising a 
signed program agreement.
    Response: We will provide the PO and the SAA with written 
notification of any revisions and include updated pages of the program 
agreement. The PO and the SAA have 30 days to send written notification 
to us of any disagreement with the revisions. We have provided 
information on the program agreement on the PACE home page, in the PACE 
Fact Sheet, which is located at http://www.cms.hhs.gov/PACE/Downloads/PACEFactSheet.pdf
.

    Comment: One commenter asked that we define the procedure for 
expanding a service area.
    Response: The procedure for expanding a service area differs 
depending on whether a new PACE center is also being opened. The 
abbreviated PACE expansion application and additional information 
regarding the procedures for expanding a service area on the PACE home 
page, in the PACE Fact Sheet, which is located at http://www.cms.hhs.gov/PACE/Downloads/PACEFactSheet.pdf
.

    Comment: Two commenters asked when we would provide the 
requirements on standard quality measures, the requirements for 
participant care data and information and asked whether the 
requirements are the same for all PACE programs. A number of commenters 
inquired when the data would be collected and what the specific 
measures would be.
    Response: The program agreement identifies the data elements for 
monitoring that must be submitted quarterly by all POs. A further 
discussion on standard quality measures, Outcome-Based Continuous 
Quality Improvement (OBCQI), and COCOA-B is in section III subpart H of 
this final rule.
    Comment: Commenters asked when CMS would provide the Medicare 
capitation rates.
    Response: Section 1894(d) of the Act directs the Secretary to make 
prospective monthly payments of a capitation amount for each PACE 
program eligible individual enrolled under the agreement under this 
section in the same manner and from the same sources as payments are 
made to the Medicare+Choice (formerly M+C, now MA) organizations and to 
specify the capitation amount in the PACE program agreement. Therefore, 
in the 1999 interim final rule, we required that the Medicare 
capitation rates be included in the program agreement. The Balanced 
Budget Act of 1997(BBA) mandated that a risk adjustment payment 
methodology incorporating information on beneficiaries' health status 
be implemented in the M+C program. The resulting PACE payment 
methodology that began in 2004 includes a risk adjusted methodology 
that results in a unique payment for each participant. As a result, it 
is not possible to include the Medicare capitation rates in the program 
agreement. Therefore, we are amending our regulation to remove the 
requirement that the program agreement include the Medicare capitation 
amount and to require, instead, that the program agreement must include 
the Medicare payment methodology. This requirement is included in 
Appendix ``M'' of the program agreement, which can be found at http://www.cms.hhs.gov/pace/Downloads/programagreement.pdf.
 Medicare rates are 

annually updated, published, and posted on the CMS Web site. Current 
Medicare payment rates can be found at http://www.cms.hhs.gov/healthplans/rates/default.asp
.

    Final rule actions:
    This final rule will amend Sec.  460.32 to indicate that the 
program agreement must include the ``Medicare payment methodology'' 
which replaces the ``Medicare capitation rate.''

Section 460.34 Duration of PACE Program Agreement

    In Sec.  460.34, we specify that each program agreement will be 
effective for a contract year, but may be extended for additional 
contract years in the absence of a notice by a party to terminate, in 
accordance with the requirements of sections 1894(e)(2)(A)(iii) and 
1934(e)(2)(A)(iii) of the Act.
    Comment: It was recommended that we extend the program agreement's 
designated 1-year contract period to a longer period of time with an 
automatic extender.
    Response: As noted above, the statute specifies a 1-year 
contracting period. We provided for a flexible initial contract year 
that could be as long as 23 months to allow us to adjust the length of 
the initial or start-up contract year so that subsequent years are on a 
standard calendar year cycle.
    PACE program agreements are considered to be ``evergreen'' meaning 
they will be automatically renewed without having to be re-signed. We 
believe the term of the program agreement is appropriate and consistent 
with overall Medicare policy, as well as in compliance with the 
requirements of the Act.
    Final rule actions:
    This final rule will finalize Sec.  460.34 as published in the 1999 
interim final rule.

Subpart D--Sanctions, Enforcement Actions and Termination

    In subpart D of the 1999 interim final rule, we specified the 
violations identified in sections 1857(g)(1) and 1903(m)(5)(A) of the 
Act that could result in the imposition of sanctions under sections 
1894(e)(6) and 1934(e)(6) of the Act. We also specified in accordance 
with paragraph (e)(5) of section 1894 and 1934 of the Act, that CMS or 
the SAA may terminate the PACE program agreement at any time for cause 
and that a PO may terminate an agreement after appropriate notice to 
CMS, the SAA, and participants. We also specified, in accordance with 
paragraphs (e)(5)(C) of sections 1894 and 1934(e)(5)(C) of the Act, 
Part IX of the Protocol, the transition procedures that must be 
followed by an entity

[[Page 71259]]

whose PACE program agreement is in the process of being terminated. 
Those procedures can be found in Sec.  460.50.

Section 460.40 Violations for Which CMS May Impose Sanctions

    In Sec.  460.40 we specified, based on paragraph (e)(6)(B) of 
sections 1894 and 1934 of the Act, that we can impose, in addition to 
any other remedies authorized by law, any of three types of sanctions 
if we determine that a PO has committed any of nine listed violations. 
The following PO violations specified in this section are based on 
provisions of sections 1857(g)(1) and 1903(m)(5)(A) of the Act:
     Fails substantially to furnish to a participant medically 
necessary items and services that are covered PACE services, if the 
failure has adversely affected (or has substantial likelihood of 
adversely affecting) the participant.
     Involuntarily disenrolls a participant in violation of 
Sec.  460.164.
     Discriminates in enrollment or disenrollment among 
Medicare beneficiaries or Medicaid recipients, or both, who are 
eligible to enroll in a PACE program, on the basis of an individual's 
health status or need for health care services.
     Engages in any practice that would reasonably be expected 
to have the effect of denying or discouraging enrollment, except as 
permitted by Sec.  460.150, by Medicare beneficiaries or Medicaid 
recipients whose medical condition or history indicates a need for 
substantial future medical services.
     Imposes charges on participants enrolled under Medicare or 
Medicaid for premiums in excess of the premiums permitted.
     Misrepresents or falsifies information that is furnished 
to CMS or the State under this part; or, to an individual or any other 
entity under this part.
     Prohibits or otherwise restricts a covered health care 
professional from advising a participant who is a patient of the 
professional about the participant's health status, medical care, or 
treatment for the participant's condition or disease, regardless of 
whether the PACE program provides benefits for that care or treatment, 
if the professional is acting within his or her lawful scope of 
practice.
     Operates a physician incentive plan that does not meet the 
requirements of section 1876(i)(8) of the Act.
     Employs or contracts with any individual who is excluded 
from participation in Medicare or Medicaid under section 1128 or 1128A 
of the Act (or with any entity that employs or contracts with such an 
individual) for the provision of health care, utilization review, 
medical social work, or administrative services.
    We received the following comments on Sec.  460.40.
    Comment: A commenter stated that the 1999 interim final rule did 
not include sanctions or enforcement actions that would apply if a 
program fails to comply with the data collection, record maintenance 
and reporting requirements in subpart L. The commenter asked what is 
the authority to require the POs to comply with these requirements.
    Response: Under the terms of the program agreement (Sec.  
460.32(a)(2)) the PO is committed to meet all applicable requirements 
under Federal, State and local laws and regulations, which would 
include the requirements under subpart L. The reporting requirements in 
subpart L impact our ability to calculate Medicare capitation payments. 
Lacking the necessary data to compute an appropriate payment, the PO 
might receive an inaccurate payment or possibly no payment at all for 
the corresponding month(s).
    Moreover, failure to submit required reports could be interpreted 
as a failure by the PO to comply substantially with conditions for a PO 
under this part (Sec.  460.50(b)(1)(ii)) or to comply with the terms of 
its PACE program agreement. Therefore, CMS and the SAA have the option 
of terminating the PACE program agreement due to uncorrected 
deficiencies.
    We believe that Sec.  460.40 as published in the 1999 interim final 
rule sufficiently addresses the availability of sanctions for 
violations of subpart L requirements.
    Comment: A commenter indicated it was not clear how CMS intended to 
monitor performance in an identified deficient area nor how CMS and the 
SAA would cooperate on investigations, agree on findings, and impose 
sanctions, enforcement, and termination.
    Response: In a cooperative effort, CMS and the SAA jointly perform 
onsite monitoring reviews on a regular basis to ensure quality of 
participant care as well as to verify clinical and administrative 
compliance with the PACE regulations. Both CMS and the SAAs engage in a 
collaborative relationship to sustain oversight of the PO. We stress 
communications to ensure that each party has the information necessary 
to take appropriate actions.
    Comment: A commenter also requested we clarify the violation 
incorporated into Sec.  460.40(d), which concerns practices that would 
have the effect of denying or discouraging enrollment.
    Response: Under Sec.  460.40(d), CMS may impose a sanction if the 
PO engages in any practice that would deny or discourage a participant 
from enrolling in PACE whose medical condition or history indicates a 
need for substantial medical service. The exception to this sanction is 
if the applicant is otherwise ineligible under Sec.  460.150 (that is, 
they are under 55 years of the age, they do not live in the PO's 
service area, they do not meet the level of care indicated in the 
State's Medicaid plan, living in the community would jeopardize their 
health or safety under the criteria as specified in the program 
agreement, or any additional eligibility requirements approved by CMS 
and included in the PACE provider agreement).
    Final rule actions:
    This final rule will finalize Sec.  460.40 as published in the 1999 
interim final rule.

Section 460.42 Suspension of Enrollment or Payment by CMS

    We described the two types of sanctions that we may impose in Sec.  
460.42 and Sec.  460.46 (civil money penalties). Each of the sanctions, 
or remedies, that are specified in these sections for specific 
violations are based on provisions of sections 1857(g)(2), 1857(g)(4), 
and 1903(m)(5)(B) of the Act. With respect to suspension of enrollment 
in PACE, we may suspend enrollment of Medicare beneficiaries after the 
date we notify the organization of the violation. Suspending enrollment 
of Medicaid recipients is an action taken by the SAA rather than CMS. 
With respect to suspension of payment, we may suspend Medicare payment 
to the PO and deny payment to the State of Federal financial 
participation (FFP) for medical assistance services furnished under the 
PACE program agreement.
    Comment: One commenter recommended that a decision to suspend 
enrollment should be a collaborative agreement by CMS and the SAA or 
the SAA should have the ability to do so on its own. Therefore, the 
commenter recommended establishing an expectation of collaboration 
between CMS and the SAA, at a minimum.
    The commenter also recommended that we revise Sec.  460.42(b)(2) to 
prospectively notify the State that FFP will be discontinued 60 days 
from receipt of the notice.
    Response: In the event of any violation or imposition of sanctions, 
we work closely with the SAA of the State in which the PO is located. 
The interaction between CMS and the SAA is by nature a collaborative 
one and any action decided upon is the result of this

[[Page 71260]]

collaborative effort. We do not believe that adding regulatory language 
will enhance the inherent collaborative working relationship between 
CMS and the SAAs.
    Moreover, should we exercise the sanction option at Sec.  
460.42(b)(2), we will use existing procedures and timeframes for the 
disallowance of FFP claims. These provisions can be found at 42 CFR 
430.42.
    Final rule actions:
    This final rule will finalize Sec.  460.42 as published in the 1999 
interim final rule.

Section 460.46 Civil Money Penalties

    In addition to suspension of enrollment, CMS may impose civil money 
penalties as specified in Sec.  460.46. These include penalties of 
$100,000 plus $15,000 for each individual not enrolled as a result of 
the PO's discrimination in enrollment or disenrollment or practice that 
would deny or discourage enrollment; $25,000 plus double the excess 
amount above the permitted premium charged a participant by the PO; 
$100,000 for each misrepresentation or falsification of information; 
and $25,000 for any violation specified in Sec.  460.40.
    Comment: One commenter requested clarification of CMS' authority to 
assess financial penalties for violations to dual eligible individuals 
(Medicare beneficiaries that are also Medicaid eligible individuals) as 
well as Medicare-only beneficiaries.
    Response: Authority to assess monetary penalties is provided in 
sections 1894(e)(6) (Medicare provisions) and 1934(e)(6)(Medicaid 
provisions) of the Act. If it is determined that a provider has failed 
to comply with the requirements of those sections of the Act and the 
regulations, CMS has the authority to impose monetary penalties for 
violations impacting either dual eligible or Medicare-only 
participants.
    Comment: Several commenters expressed concern that the civil 
monetary penalties for POs are the same or greater than those of 
Medicaid managed care and MA organizations. The commenters pointed out 
that significant size and revenue differences between MA and POs 
warrant lower penalties for POs. In addition POs have a smaller pool of 
potential participants than managed care organizations, which must 
enroll all individuals regardless of need.
    Response: We believe the current requirement as published is 
appropriate in that it allows for imposition of a range of penalty 
amount from one dollar up to and including the amounts identified in 
Sec.  460.48. It is not CMS' intent to close any PACE program. We 
believe the imposition of the maximum financial penalty is an option 
that would only be used in cases of egregious violations. We believe it 
is appropriate to maintain the current regulatory requirements, which 
provide CMS the ability to impose a broad range of penalty amounts 
including the maximum sanction should the situation warrant.
    Comment: Six commenters indicated that the level of penalties is 
too severe and recommend the penalties be proportionate to the size of 
the PACE program. One commenter recommended penalties be left to the 
discretion of the State, while several others indicated that an 
appropriate amount would be one-quarter of the amount required for 
Medicaid managed care and M+C plans.
    Response: As noted in the previous response, the rule permits a 
range of amounts to be imposed and provides CMS with the necessary 
flexibility to impose an appropriate amount depending upon the nature 
of the violation. In addition, we note that statute requires CMS to 
make the determination (after consultation with the SAA) to impose any 
sanctions.
    Comment: One commenter relayed the regulation did not indicate to 
whom the fines should be paid. They recommended the fines be shared 
equally between the Federal government and the SAA.
    Response: Should CMS impose a fine, the PO will be informed in 
writing and directed where to send the penalty. The PACE statute and 
regulations at Sec.  460.46(b) specify that section 1128A of the Act 
governs disposition of civil money penalties. It is not the purpose of 
this rule to further address disposition of amounts recovered.
    Final rule actions:
    This final rule will finalize Sec.  460.46 as published in the 1999 
interim final rule.

Section 460.48 Additional Actions by CMS or the State

    In Sec.  460.48 we specified, based on paragraph (e)(6)(A) of 
sections 1894 and 1934 of the Act, that if CMS, after consultation with 
the SAA, determines that a PO is not in substantial compliance with 
requirements in these regulations, CMS or the SAA can take one or more 
of the following actions: Condition the continuation of the PACE 
program agreement upon timely execution of a corrective action plan; 
withhold some or all payments under the PACE program agreement until 
the organization corrects the deficiency; or terminate the program 
agreement.
    Comment: One commenter questioned whether CMS and the SAA could 
independently take action against a PO for violations providing there 
was prior consultation.
    Response: The statute allows CMS to take an enforcement action but 
only after CMS has consulted with the SAA, and determines that the PACE 
provider has failed substantially to comply with the PACE requirements. 
While the SAA may take action based on its own regulations, we believe, 
that in light of the collaborative relationship between CMS and the 
SAA, the SAA would consult with CMS before taking any independent 
action.
    Final rule actions:
    This final rule will finalize Sec.  460.48 as published in the 1999 
interim final rule.

Section 460.50 Termination of PACE Program Agreement

    In Sec.  460.50 we specified, in accordance with paragraph 
(e)(5)(A) of sections 1894 and 1934 of the Act, that CMS or a SAA may 
terminate at any time a PACE program agreement for cause and that a PO 
may terminate an agreement after appropriate notice to CMS, the SAA, 
and its participants. In accordance with paragraph (e)(5)(B) of 
sections 1894 and 1934 of the Act, we specified that CMS or a SAA may 
terminate a PACE program agreement with a PO if CMS or the SAA 
determines that:
     Either there are significant deficiencies in the quality 
of care furnished to participants, or the PO has failed to comply 
substantially with conditions under these regulations or with the terms 
of its PACE program agreement; and
     The PO has failed to develop and successfully initiate, 
within 30 days of the date of the receipt of written notice, a plan to 
correct the deficiencies, or has failed to continue implementation of 
such a plan.
    Based on the Protocol, Part IX, section A.1, we also provided for 
termination if CMS or the SAA determines that the PO cannot ensure the 
health and safety of its participants. This determination may result 
from the identification of deficiencies, which CMS or the SAA 
determines cannot be corrected. Based on the Protocol, Part IX, section 
A.2, we also required that if the organization terminates the 
agreement, a minimum of 90 days' notice must be given to CMS and the 
SAA regarding the organization's intent and that participants must be 
given a minimum of 60 days notice.
    Comment: Termination of the PACE program and transitional care 
during transition were topics of several comments and recommendations 
we received. Recommendations included

[[Page 71261]]

adding regulatory language requiring CMS and the SAA to agree and 
coordinate their actions related to termination of a PACE program 
agreement. Another recommendation was to require that CMS and the State 
consider the likelihood of institutionalization of community 
participants in determining whether termination should be imposed.
    Response: Neither CMS nor the State considers termination lightly, 
and our primary concern is protecting the health and safety of the 
participants. All possible ramifications of terminating a program 
agreement, including the likelihood of participants becoming 
institutionalized, will be considered before taking such a severe 
action. However, we disagree with the commenters and do not believe 
revisions to the regulations are warranted. As stated in response to 
previous commenters, we believe the cooperative nature of the 
relationships between CMS and the SAAs will lead to agreement on a 
decision to terminate a program agreement. We note however, the statute 
and regulations specify that CMS or the SAA may independently terminate 
a PACE program agreement.
    Comment: A commenter suggested that the regulations include the 
appointment of a temporary manager to supervise the operation of the 
PACE program as an alternative to termination of the program agreement.
    Response: To date our experience with the POs does not indicate the 
necessity of including this remedy in regulation. We will continue to 
assess the performance of POs and we may consider this sanction in the 
future. We note that Sec.  460.48(a) states that CMS or the SAA may 
condition continuation of the PACE program agreement upon timely 
execution of a corrective action plan (CAP). The appointment of a 
``temporary manager'' could be included within the provisions of a CAP. 
As such, it would be unnecessary to specify specific remedies 
(including a temporary manager) that CMS might include in the CAP for a 
particular PO.
    Final rule actions:
    This final rule will finalize Sec.  460.50 as published in the 1999 
interim final rule.

Section 460.52 Transitional Care During Termination

    Based on the Protocol, Part IX, section B, we require that the PO 
develop a detailed written plan for phase-down in the event of 
termination which includes the following: The process for informing 
participants, the community, CMS and the SAA in writing about 
termination and transition procedures; and steps that will be taken to 
help assist participants to obtain reinstatement of conventional 
Medicare and Medicaid benefits, transition their care to other 
providers, and terminate marketing and enrollment